306 related articles for article (PubMed ID: 21599546)
1. The relationship among proton pump inhibitors, bone disease and fracture.
Targownik LE; Leslie WD
Expert Opin Drug Saf; 2011 Nov; 10(6):901-12. PubMed ID: 21599546
[TBL] [Abstract][Full Text] [Related]
2. Proton pump-inhibiting drugs, calcium homeostasis, and bone health.
Wright MJ; Proctor DD; Insogna KL; Kerstetter JE
Nutr Rev; 2008 Feb; 66(2):103-8. PubMed ID: 18254877
[TBL] [Abstract][Full Text] [Related]
3. Fracture risk and bone mineral density reduction associated with proton pump inhibitors.
Lau YT; Ahmed NN
Pharmacotherapy; 2012 Jan; 32(1):67-79. PubMed ID: 22392829
[TBL] [Abstract][Full Text] [Related]
4. [Proton pump inhibitor and bone complications].
Soen S
Clin Calcium; 2015 Nov; 25(11):1667-74. PubMed ID: 26503872
[TBL] [Abstract][Full Text] [Related]
5. Proton pump inhibitors, osteoporosis, and osteoporosis-related fractures.
Fournier MR; Targownik LE; Leslie WD
Maturitas; 2009 Sep; 64(1):9-13. PubMed ID: 19674854
[TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors and bone fractures?
Laine L
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S21-6. PubMed ID: 19262543
[TBL] [Abstract][Full Text] [Related]
7. The relationship between long-term proton pump inhibitor therapy and skeletal frailty.
Lau AN; Tomizza M; Wong-Pack M; Papaioannou A; Adachi JD
Endocrine; 2015 Aug; 49(3):606-10. PubMed ID: 25948072
[TBL] [Abstract][Full Text] [Related]
8. The effect of proton pump-inhibiting drugs on mineral metabolism.
Insogna KL
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S2-4. PubMed ID: 19262542
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitor use and fracture risk - effect modification by histamine H1 receptor blockade. Observational case-control study using National Prescription Data.
Abrahamsen B; Vestergaard P
Bone; 2013 Nov; 57(1):269-71. PubMed ID: 23973557
[TBL] [Abstract][Full Text] [Related]
10. PPIs and fracture risk.
Med Lett Drugs Ther; 2013 Feb; 55(1410):15-6. PubMed ID: 23459458
[No Abstract] [Full Text] [Related]
11. Increased Risk of Bone Fractures in Hemodialysis Patients Treated with Proton Pump Inhibitors in Real World: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS).
Fusaro M; D'Arrigo G; Pitino A; Iervasi G; Tentori F; Robinson B; Aghi A; Bieber B; Mccullogh K; Fabris F; Plebani M; Giannini S; Gallieni M; Tripepi G
J Bone Miner Res; 2019 Dec; 34(12):2238-2245. PubMed ID: 31365145
[TBL] [Abstract][Full Text] [Related]
12. Proton pump inhibitors and risk of fracture: a systematic review and meta-analysis of observational studies.
Ngamruengphong S; Leontiadis GI; Radhi S; Dentino A; Nugent K
Am J Gastroenterol; 2011 Jul; 106(7):1209-18; quiz 1219. PubMed ID: 21483462
[TBL] [Abstract][Full Text] [Related]
13. Proton pump inhibitors and risk of hip fracture: a meta-analysis of observational studies.
Poly TN; Islam MM; Yang HC; Wu CC; Li YJ
Osteoporos Int; 2019 Jan; 30(1):103-114. PubMed ID: 30539272
[TBL] [Abstract][Full Text] [Related]
14. The relationship between proton pump inhibitor adherence and fracture risk in the elderly.
Ding J; Heller DA; Ahern FM; Brown TV
Calcif Tissue Int; 2014 Jun; 94(6):597-607. PubMed ID: 24706060
[TBL] [Abstract][Full Text] [Related]
15. Considerations for the use of proton-pump inhibitors in older adults.
Desilets AR; Asal NJ; Dunican KC
Consult Pharm; 2012 Feb; 27(2):114-20. PubMed ID: 22330952
[TBL] [Abstract][Full Text] [Related]
16. Long-term proton pump inhibitor therapy and falls and fractures in elderly women: a prospective cohort study.
Lewis JR; Barre D; Zhu K; Ivey KL; Lim EM; Hughes J; Prince RL
J Bone Miner Res; 2014 Nov; 29(11):2489-97. PubMed ID: 24825180
[TBL] [Abstract][Full Text] [Related]
17. Indications and safety of proton pump inhibitor drug use in patients with cancer.
Triadafilopoulos G; Roorda AK; Akiyama J
Expert Opin Drug Saf; 2013 Sep; 12(5):659-72. PubMed ID: 23647006
[TBL] [Abstract][Full Text] [Related]
18. Use of proton pump inhibitors is associated with fractures in young adults: a population-based study.
Freedberg DE; Haynes K; Denburg MR; Zemel BS; Leonard MB; Abrams JA; Yang YX
Osteoporos Int; 2015 Oct; 26(10):2501-7. PubMed ID: 25986385
[TBL] [Abstract][Full Text] [Related]
19. [Emergent adverse effects of proton pump inhibitors].
Bourne C; Charpiat B; Charhon N; Bertin C; Gouraud A; Mouchoux C; Skalli S; Janoly-Dumenil A
Presse Med; 2013 Feb; 42(2):e53-62. PubMed ID: 23237784
[TBL] [Abstract][Full Text] [Related]
20. Proton pump inhibitor use and the antifracture efficacy of alendronate.
Abrahamsen B; Eiken P; Eastell R
Arch Intern Med; 2011 Jun; 171(11):998-1004. PubMed ID: 21321287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
